8-K
Bowhead Specialty Holdings Inc. (BOW)
View as plain text
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 24, 2026
Bowhead Specialty Holdings Inc.
(Exact name of registrant as specified in its charter)
| Delaware | 001-42111 | 87-1433334 |
|---|---|---|
| (State or other jurisdiction<br><br>of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
| 452 Fifth Avenue<br><br>New York, New York 10018 | ||
| (Address of principal executive offices) | ||
| (212) 970-0269 | ||
| (Registrant’s telephone number, including area code) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
£ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
£ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
£ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
£ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
|---|---|---|
| Common Stock, par value $0.01 per share | BOW | New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 under the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 under the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company T
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. £
Item 2.02 Results of Operations and Financial Condition.
On February 24, 2026, Bowhead Specialty Holdings Inc. (the "Company") issued a press release announcing its financial results for the three months and twelve months ended December 31, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
Item 7.01 Regulation FD Disclosure.
On February 24, 2026, the Company made available to investors an investor presentation for the period ended December 31, 2025 (the "Investor Presentation"). The Investor Presentation is furnished as Exhibit 99.2 hereto. The Investor Presentation is also available on the Investors section of the Company's website, free of charge, at https://ir.bowheadspecialty.com.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
| Exhibit No. | Description |
|---|---|
| 99.1 | Press Release of the Company, dated February 24, 2026 |
| 99.2 | Bowhead Specialty Holdings Inc. Investor Presentation for the period endedDecember31, 2025 |
| 104 | Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: February 24, 2026
| By: | /s/Brad Mulcahey |
|---|---|
| Name: | Brad Mulcahey |
| Title: | Chief Financial Officer and Treasurer |
Document

Bowhead Specialty Holdings Inc. Reports Fourth Quarter and Full Year 2025 Results
NEW YORK, New York. (BusinessWire) – February 24, 2026 – Bowhead Specialty Holdings Inc. (NYSE: BOW), a specialty lines insurance group focused on providing casualty, professional liability and healthcare liability insurance products, delivered through complementary “craft” and “digital” underwriting models, today announced financial results for the fourth quarter and year ended December 31, 2025(1).
Fourth Quarter 2025 Highlights
•Gross written premiums increased 21.3% to $224.1 million.
•Net income of $14.8 million, or $0.44 per diluted share.
•Adjusted net income(2) of $15.5 million, or $0.47 per diluted share(2).
•Return on equity of 13.5% and adjusted return on equity(2) of 14.1%.
•Book value per share $13.70 and diluted book value per share of $13.45.
Full Year 2025 Highlights
•Gross written premiums increased 24.0% to $862.8 million.
•Net income of $53.8 million, or $1.59 per diluted share.
•Adjusted net income(2) of $55.6 million, or $1.65 per diluted share(2).
•Return on equity of 13.1% and adjusted return on equity(2) of 13.6%.
Bowhead Chief Executive Officer, Stephen Sills, commented, “Bowhead had a great year in 2025. Gross written premiums grew more than 21% in the fourth quarter, and 24% for the full year. At the start of the year, we expected a low 30s expense ratio for the full year of 2025 but achieved an expense ratio below 30% starting in the third quarter and for the full year of 2025. With these accomplishments, Bowhead’s adjusted net income for the year grew over 30%, adjusted return on equity was 13.6%, and diluted adjusted earnings per share was $1.65.”
“With a strong year behind us, I’m even more excited about Bowhead’s future. Over the past five years, we’ve built a highly effective “craft” underwriting model driven by experienced underwriters who excel at writing large and complex risks. In the second half of 2024, we supplemented this foundation by launching our complementary “digital” underwriting model, starting with Baleen, targeting small, harder-to-place risks with more restrictive coverage. In Baleen’s first full year, we generated over $21 million in premiums — an important milestone that validates our digital strategy. Since then, we’ve leveraged technology to streamline the submission, underwriting, and servicing of our existing Bowhead products, a capability we call “express”, to address small and mid-sized accounts, beginning with our small cyber liability products.”
“While we continue to expect a GWP growth of around 20% in 2026 driven by our Casualty division, our digital expansion marks a major step forward for Bowhead, positioning us well to deliver sustainable and profitable growth across market cycles.”
Underwriting Results
The 21.3% increase in gross written premiums to $224.1 million in the fourth quarter of 2025 was driven by our increasing renewal book, new business and the continued growth in our platform across all divisions:
•Our Casualty division led the growth with a 25.5% increase to $132.9 million;
•Professional Liability increased 4.2% to $47.9 million;
•Healthcare Liability increased 7.7% to $34.2 million; and
•Baleen Specialty increased 665.6% to $9.1 million.
Due to the timing of our independent actuarial review in fourth quarter of each year, we consider our full-year loss ratio a more meaningful metric. Our loss ratio for the year of 66.7% increased 2.3 points compared to 64.4% in 2024.

Our current accident year loss ratio increased 1.8 points due in part to higher expected loss ratios on certain reserves within Professional Liability and Healthcare Liability to align more closely with industry expected loss ratios and our own limited loss experience. The increase was also due to mix changes in our portfolio, where Casualty, which had comparatively higher expected loss ratios, comprised a larger proportion of our net earned premiums compared to the prior year.
Similar to previous quarters in 2025, the 0.5 point increase in our prior accident year loss ratio was due to expected loss ratios applied to audit premiums fully earned in the year, but associated with prior accident years. This increase was not based on actual losses settling for more than reserved, and did not represent an increase in estimated reserves on unresolved claims. We are simply putting loss reserves into the appropriate accident year regardless of when the premiums are billed and earned. As part of our annual independent actuarial reserve review, we also reallocated prior accident year loss reserves between accident years and by division, primarily from Casualty to Professional Liability, resulting in no prior accident year development on an aggregate basis.
Due to Bowhead’s limited loss experience, we continue to hold expected loss ratios that rely on development patterns and other inputs primarily based on industry data.
Our expense ratio decreased 1.0 point to 29.1% in the fourth quarter of 2025 and 1.6 points to 29.8% in for the year ended December 31, 2025. The full year decrease from 31.4% in 2024 was primarily driven by a reduction in our operating expense ratio, which was partially offset by the increase in our net acquisition ratio. The decrease in our operating expenses ratio was due to the continued scaling of our business, where net earned premiums grew at a higher rate than our expenses, as well as the prudent management of our expenses. The increase in our net acquisition costs ratio was driven by the increase in earned broker commissions due to changes in our portfolio mix and, to a lesser extent, the increase in the ceding fee we pay to American Family.
Investment Results
Net investment income increased 35.8% in the fourth quarter of 2025 to $16.6 million and 44.1% to $57.8 million for the year ended December 31, 2025, driven by a higher balance of investments and, to a lesser extent, higher yields on invested assets. Our investment portfolio, which included cash equivalents, had a book yield of 4.6% and a new money rate of 4.5% at the end of the year.
The weighted average effective duration of our investment portfolio, which included cash equivalents, was 3.0 years and had an average rating of “AA” at December 31, 2025.
__________________
(1)Comparisons in this release are made to December 31, 2024 financial results unless otherwise noted.
(2)Non-GAAP financial measure. See “Reconciliation of Non-GAAP Financial Measures” for a reconciliation of the non-GAAP financial measures to their most directly comparable U.S. GAAP measures.

Summary of Operating Results
The following table summarizes the Company’s results of operations for the three and twelve months ended December 31, 2025 and 2024:
| Three Months Ended December 31, | Twelve Months Ended December 31, | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 2024 | % Change | 2025 | 2024 | % Change | ||||||||||
| ( in thousands, except percentages and per share data) | |||||||||||||||
| Gross written premiums | $ | 184,769 | 21.3 | % | $ | 862,806 | $ | 695,717 | 24.0 | % | |||||
| Ceded written premiums | (80,540) | (64,585) | 24.7 | % | (304,619) | (244,295) | 24.7 | % | |||||||
| Net written premiums | $ | 120,184 | 19.4 | % | $ | 558,187 | $ | 451,422 | 23.7 | % | |||||
| Revenues | |||||||||||||||
| Net earned premiums | $ | 106,864 | 25.7 | % | $ | 491,677 | $ | 385,111 | 27.7 | % | |||||
| Net investment income | 16,553 | 12,193 | 35.8 | % | 57,827 | 40,121 | 44.1 | % | |||||||
| Net realized investment gains (losses) | 73 | — | NM | 43 | (16) | 368.8 | % | ||||||||
| Other insurance-related income | 735 | 274 | 168.2 | % | 2,042 | 444 | 359.9 | % | |||||||
| Total revenues | 151,678 | 119,331 | 27.1 | % | 551,589 | 425,660 | 29.6 | % | |||||||
| Expenses | |||||||||||||||
| Net losses and loss adjustment expenses | 91,087 | 66,937 | 36.1 | % | 328,022 | 248,099 | 32.2 | % | |||||||
| Net acquisition costs | 13,166 | 9,130 | 44.2 | % | 46,513 | 32,397 | 43.6 | % | |||||||
| Operating expenses | 26,640 | 23,352 | 14.1 | % | 102,264 | 89,112 | 14.8 | % | |||||||
| Non-operating expenses | 95 | 622 | (84.7) | % | 1,425 | 2,807 | (49.2) | % | |||||||
| Warrant expense | 792 | 792 | NM | 3,142 | 1,917 | 63.9 | % | ||||||||
| Interest expense and financing fees | 1,243 | 248 | 401.2 | % | 2,012 | 725 | 177.5 | % | |||||||
| Loss on extinguishment of credit facility | 862 | — | NM | 862 | — | NM | |||||||||
| Foreign exchange (gains) losses | (14) | 1 | NM | 50 | 68 | (26.5) | % | ||||||||
| Total expenses | 133,871 | 101,082 | 32.4 | % | 484,290 | 375,125 | 29.1 | % | |||||||
| Income before income taxes | 17,807 | 18,249 | (2.4) | % | 67,299 | 50,535 | 33.2 | % | |||||||
| Income tax expense | (2,963) | (4,642) | (36.2) | % | (13,513) | (12,292) | 9.9 | % | |||||||
| Net income | $ | 13,607 | 9.1 | % | $ | 53,786 | $ | 38,243 | 40.6 | % | |||||
| Key Operating and Financial Metrics: | |||||||||||||||
| Adjusted net income(1) | $ | 14,099 | 10.2 | % | $ | 55,598 | $ | 42,686 | 30.2 | % | |||||
| Loss ratio | 67.8 | % | 62.6 | % | 66.7 | % | 64.4 | % | |||||||
| Expense ratio | 29.1 | % | 30.1 | % | 29.8 | % | 31.4 | % | |||||||
| Combined ratio | 96.9 | % | 92.7 | % | 96.5 | % | 95.8 | % | |||||||
| Return on equity(2) | 13.5 | % | 14.8 | % | 13.1 | % | 13.6 | % | |||||||
| Adjusted return on equity(1)(2) | 14.1 | % | 15.3 | % | 13.6 | % | 15.2 | % | |||||||
| Diluted earnings per share | $ | 0.41 | 7.3 | % | $ | 1.59 | $ | 1.29 | 23.3 | % | |||||
| Diluted adjusted earnings per share(1) | $ | 0.42 | 11.9 | % | $ | 1.65 | $ | 1.44 | 14.6 | % |
All values are in US Dollars.
__________________
NM - Percentage change is not meaningful.
(1)Non-GAAP financial measure. See “Reconciliation of Non-GAAP Financial Measures” for a reconciliation of the non-GAAP financial measures to their most directly comparable U.S. GAAP measures.
(2)For the three months ended December 31, 2025 and 2024, net income and adjusted net income are annualized to arrive at return on equity and adjusted return on equity.

Condensed Consolidated Balance Sheets
| December 31,<br>2024 | ||
|---|---|---|
| Assets | ||
| Investments | ||
| Fixed maturity securities, available for sale, at fair value (amortized cost of 1,364,228 and 894,145, respectively) | $ | 879,989 |
| Short-term investments, at amortized cost, which approximates fair value | 9,997 | |
| Total investments | 889,986 | |
| Cash and cash equivalents | 97,476 | |
| Restricted cash and cash equivalents | 124,582 | |
| Accrued investment income | 7,520 | |
| Premium balances receivable | 63,672 | |
| Reinsurance recoverable, net | 255,072 | |
| Prepaid reinsurance premiums | 152,567 | |
| Deferred policy acquisition costs | 27,625 | |
| Property and equipment, net | 6,845 | |
| Income taxes receivable | 586 | |
| Deferred tax assets, net | 20,340 | |
| Other assets | 7,971 | |
| Total assets | $ | 1,654,242 |
| Liabilities | ||
| Reserve for losses and loss adjustment expenses | $ | 756,859 |
| Unearned premiums | 446,850 | |
| Reinsurance balances payable | 51,856 | |
| Debt | — | |
| Income taxes payable | 1,571 | |
| Accrued expenses | 18,010 | |
| Other liabilities | 8,654 | |
| Total liabilities | 1,283,800 | |
| Commitments and contingencies (Note 14) | ||
| Mezzanine equity | ||
| Performance stock units | 265 | |
| Stockholders' equity | ||
| Common stock | 327 | |
| (0.01 par value; 400,000,000 shares authorized, 32,783,451 and 32,662,683 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively) | ||
| Additional paid-in capital | 318,095 | |
| Accumulated other comprehensive income (loss) | (11,154) | |
| Retained earnings | 62,909 | |
| Total stockholders' equity | 370,177 | |
| Total mezzanine equity and stockholders' equity | 370,442 | |
| Total liabilities, mezzanine equity and stockholders' equity | $ | 1,654,242 |
All values are in US Dollars.

Gross Written Premiums
The following tables present gross written premiums by underwriting division for the three and twelve months ended December 31, 2025 and 2024:
| Three Months Ended December 31, | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | % of Total | 2024 | % of Total | Change | % Change | |||||
| ( in thousands, except percentages) | ||||||||||
| Casualty | 59.3 | % | $ | 105,872 | 57.3 | % | 25.5 | % | ||
| Professional Liability | 47,928 | 21.4 | % | 46,010 | 24.9 | % | 1,918 | 4.2 | % | |
| Healthcare Liability | 34,153 | 15.2 | % | 31,699 | 17.2 | % | 2,454 | 7.7 | % | |
| Baleen Specialty | 9,095 | 4.1 | % | 1,188 | 0.6 | % | 7,907 | 665.6 | % | |
| Gross written premiums | 100.0 | % | $ | 184,769 | 100.0 | % | 21.3 | % |
All values are in US Dollars.
| Twelve Months Ended December 31, | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | % of Total | 2024 | % of Total | Change | % Change | |||||
| ( in thousands, except percentages) | ||||||||||
| Casualty | 63.8 | % | $ | 431,817 | 62.1 | % | 27.5 | % | ||
| Professional Liability | 174,419 | 20.2 | % | 160,651 | 23.1 | % | 13,768 | 8.6 | % | |
| Healthcare Liability | 116,290 | 13.5 | % | 101,619 | 14.6 | % | 14,671 | 14.4 | % | |
| Baleen Specialty | 21,431 | 2.5 | % | 1,630 | 0.2 | % | 19,801 | 1214.8 | % | |
| Gross written premiums | 100.0 | % | $ | 695,717 | 100.0 | % | 24.0 | % |
All values are in US Dollars.
The following tables present gross written premiums by underwriting model(1) for the three and twelve months ended December 31, 2025 and 2024:
| Three Months Ended December 31, | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | % of Total | 2024 | % of Total | Change | % Change | |||||
| ( in thousands, except percentages) | ||||||||||
| Craft | 95.2 | % | $ | 183,581 | 99.4 | % | 16.2 | % | ||
| Digital | ||||||||||
| Baleen Specialty | 9,095 | 4.1 | % | 1,188 | 0.6 | % | 7,907 | 665.6 | % | |
| Express | 1,673 | 0.7 | % | — | — | % | 1,673 | NM | ||
| Digital | 10,768 | 4.8 | % | 1,188 | 0.6 | % | 9,580 | 806.4 | % | |
| Gross written premiums | 100.0 | % | $ | 184,769 | 100.0 | % | 21.3 | % |
All values are in US Dollars.
| Twelve Months Ended December 31, | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | % of Total | 2024 | % of Total | Change | % Change | |||||
| ( in thousands, except percentages) | ||||||||||
| Craft | 97.2 | % | $ | 694,087 | 99.8 | % | 20.9 | % | ||
| Digital | ||||||||||
| Baleen Specialty | 21,431 | 2.5 | % | 1,630 | 0.2 | % | 19,801 | 1214.8 | % | |
| Express | 2,370 | 0.3 | % | — | — | % | 2,370 | NM | ||
| Digital | 23,801 | 2.8 | % | 1,630 | 0.2 | % | 22,171 | 1360.2 | % | |
| Gross written premiums | 100.0 | % | $ | 695,717 | 100.0 | % | 24.0 | % |
All values are in US Dollars.
__________________
(1)Our products are delivered through two complementary underwriting models designed to support sustainable and profitable growth across market cycles: a “craft” model for large, complex, higher-severity risks, and a “digital” model, which includes Baleen Specialty and other small-business offerings (“express”), for smaller, simpler, scalable business.

Loss Ratio
The following tables summarize current and prior accident year loss ratios for the three and twelve months ended December 31, 2025 and 2024:
| Three Months Ended December 31, | |||||||
|---|---|---|---|---|---|---|---|
| 2025 | 2024 | ||||||
| Net Losses and Loss Adjustment Expenses | % of Net Earned Premiums | Net Losses and Loss Adjustment Expenses | % of Net Earned Premiums | ||||
| ( in thousands, except percentages) | |||||||
| Current accident year | 67.5 | % | $ | 66,937 | 62.6 | % | |
| Prior accident year(1) | 361 | 0.3 | % | — | — | % | |
| Total | 67.8 | % | $ | 66,937 | 62.6 | % |
All values are in US Dollars.
| Twelve Months Ended December 31, | |||||||
|---|---|---|---|---|---|---|---|
| 2025 | 2024 | ||||||
| Net Losses and Loss Adjustment Expenses | % of Net Earned Premiums | Net Losses and Loss Adjustment Expenses | % of Net Earned Premiums | ||||
| ( in thousands, except percentages) | |||||||
| Current accident year | 66.2 | % | $ | 248,099 | 64.4 | % | |
| Prior accident year(1) | 2,369 | 0.5 | % | — | — | % | |
| Total | 66.7 | % | $ | 248,099 | 64.4 | % |
All values are in US Dollars.
__________________
(1)Prior accident year loss ratios for the three and twelve months ended December 31, 2025 were driven by expected loss ratios applied to audit premiums fully earned in the period, but associated with prior accident years. This increase was not based on actual losses settling for more than reserved, and did not represent an increase in estimated reserves on unresolved claims.

Expense Ratio
The following tables summarize the components of our expense ratios for the three and twelve months ended December 31, 2025 and 2024:
| Three Months Ended December 31, | |||||||
|---|---|---|---|---|---|---|---|
| 2025 | 2024 | ||||||
| Expenses | % of Net Earned Premiums | Expenses | % of Net Earned Premiums | ||||
| ( in thousands, except percentages) | |||||||
| Net acquisition costs | 9.8 | % | $ | 9,130 | 8.5 | % | |
| Operating expenses | 26,640 | 19.8 | % | 23,352 | 21.9 | % | |
| Less: Other insurance-related income | (735) | (0.5) | % | (274) | (0.3) | % | |
| Total | 29.1 | % | $ | 32,208 | 30.1 | % |
All values are in US Dollars.
| Twelve Months Ended December 31, | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2025 | 2024 | ||||||||
| Expenses | % of Net Earned Premiums | Expenses | % of Net Earned Premiums | ||||||
| ( in thousands, except percentages) | |||||||||
| Net acquisition costs | 9.5 | % | $ | 32,397 | 8.4 | % | |||
| Operating expenses | 102,264 | 20.8 | % | 89,112 | 23.1 | % | |||
| Less: Other insurance-related income | (2,042) | (0.4) | % | (444) | (0.1) | % | |||
| Total | 29.8 | % | $ | — | $ | 121,065 | 31.4 | % |
All values are in US Dollars.
Net Investment Income
The following table summarizes the sources of net investment income for the three and twelve months ended December 31, 2025 and 2024:
| Three Months Ended December 31, | Twelve Months Ended December 31, | ||||||
|---|---|---|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | ||||
| ( in thousands) | |||||||
| U.S. government and government agency | $ | 3,198 | $ | 5,926 | $ | 14,514 | |
| State and municipal | 1,283 | 591 | 3,904 | 1,832 | |||
| Commercial mortgage-backed securities | 1,944 | 981 | 5,808 | 2,584 | |||
| Residential mortgage-backed securities | 3,903 | 2,399 | 13,060 | 6,517 | |||
| Asset-backed securities | 1,650 | 1,283 | 6,375 | 3,043 | |||
| Corporate | 5,247 | 2,154 | 17,459 | 5,768 | |||
| Short-term investments | — | 130 | 214 | 480 | |||
| Cash and cash equivalents | 1,964 | 1,700 | 6,244 | 6,193 | |||
| Gross investment income | 16,877 | 12,436 | 58,990 | 40,931 | |||
| Investment expenses | (324) | (243) | (1,163) | (810) | |||
| Net investment income | $ | 12,193 | $ | 57,827 | $ | 40,121 |
All values are in US Dollars.

Reconciliation of Non-GAAP Financial Measures
This earnings release contains certain financial measures that are not presented in accordance with generally
accepted accounting principles in the United States (“U.S. GAAP”). We use these non-GAAP financial measures
when planning, monitoring and evaluating our performance. Management believes that each of the non-GAAP
financial measures described below provides useful insight into our underlying business performance.
•Adjusted net income is defined as net income excluding the impact of net realized investment gains (losses), non-operating expenses, loss on extinguishment of credit facility, foreign exchange losses (gains), and certain strategic initiatives. Adjusted net income excludes the impact of certain items that may not be indicative of underlying business trends, operating results, or future outlook, net of tax impact. We calculate the tax impact only on adjustments that would be included in calculating our income tax expense using the estimated tax rate at which we received a deduction for these adjustments.
•Adjusted return on equity is defined as adjusted net income as a percentage of average beginning and ending mezzanine equity and stockholders’ equity.
•Diluted adjusted earnings per share is defined as adjusted net income divided by the weighted average common shares outstanding for the period, reflecting the dilution that may occur if equity based awards are converted into common stock equivalents as calculated using the treasury stock method.
You should not rely on these non-GAAP financial measures as a substitute for any U.S. GAAP financial measure.
While we believe that these non-GAAP financial measures are useful in evaluating our business, this information
should be considered supplemental in nature and not as a replacement for or superior to the comparable U.S. GAAP
measures. In addition, other companies, including companies in our industry, may calculate such measures
differently, which reduces their usefulness as comparative measures.
Adjusted net income
Adjusted net income for the three and twelve months ended December 31, 2025 and 2024 reconciles to net income as follows:
| Three Months Ended December 31, | |||||||
|---|---|---|---|---|---|---|---|
| 2025 | 2024 | ||||||
| Before Income Taxes | After Income Taxes | Before Income Taxes | After Income Taxes | ||||
| ( in thousands) | |||||||
| Income as reported | $ | 14,844 | $ | 18,249 | $ | 13,607 | |
| Adjustments: | |||||||
| Net realized investment (gains) | (73) | (73) | — | — | |||
| Non-operating expenses | 95 | 95 | 622 | 622 | |||
| Loss on extinguishment of credit facility | 862 | 862 | — | — | |||
| Foreign exchange (gains) losses | (14) | (14) | 1 | 1 | |||
| Tax impact | — | (183) | — | (131) | |||
| Adjusted net income | $ | 15,531 | $ | 18,872 | $ | 14,099 |
All values are in US Dollars.

| Twelve Months Ended December 31, | |||||||
|---|---|---|---|---|---|---|---|
| 2025 | 2024 | ||||||
| Before Income Taxes | After Income Taxes | Before Income Taxes | After Income Taxes | ||||
| ( in thousands) | |||||||
| Income as reported | $ | 53,786 | $ | 50,535 | $ | 38,243 | |
| Adjustments: | |||||||
| Net realized investment (gains) losses | (43) | (43) | 16 | 16 | |||
| Non-operating expenses | 1,425 | 1,425 | 2,807 | 2,807 | |||
| Loss on extinguishment of credit facility | 862 | 862 | — | — | |||
| Foreign exchange losses | 50 | 50 | 68 | 68 | |||
| Strategic initiatives(1) | — | — | 2,733 | 2,733 | |||
| Tax impact | — | (482) | — | (1,181) | |||
| Adjusted net income | $ | 55,598 | $ | 56,159 | $ | 42,686 |
All values are in US Dollars.
_________________
(1)Strategic initiatives for the twelve months ended December 31, 2024 represents costs incurred to set up our Baleen Specialty division, which is recorded in operating expenses within the Consolidated Statements of Income and Comprehensive Income. The costs incurred primarily represent expenses to implement the new platform and processes supporting the Baleen Specialty division.
Adjusted return on equity
Adjusted return on equity for the three and twelve months ended December 31, 2025 and 2024 reconciles to return on equity as follows:
| Three Months Ended December 31, | Twelve Months Ended December 31, | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | ||||||||
| ( in thousands, except percentages) | |||||||||||
| Numerator: Adjusted net income(1) | $ | 56,395 | $ | 55,598 | $ | 42,686 | |||||
| Denominator: Average mezzanine equity and stockholders' equity | 440,156 | 367,467 | 409,858 | 281,259 | |||||||
| Adjusted return on equity | 14.1 | % | 15.3 | % | 13.6 | % | 15.2 | % |
All values are in US Dollars.
_______________
(1)For the three months ended December 31, 2025 and 2024, net income and adjusted net income are annualized to arrive at return on equity and adjusted return on equity.
Diluted adjusted earnings per share
Diluted adjusted earnings per share for the three and twelve months ended December 31, 2025 and 2024 reconciles to diluted earnings per share as follows:
| Three Months Ended December 31, | Twelve Months Ended December 31, | ||||||
|---|---|---|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | ||||
| ( in thousands, except share and per share data) | |||||||
| Numerator: Adjusted net income | $ | 14,099 | $ | 55,598 | $ | 42,686 | |
| Denominator: Diluted weighted average shares outstanding | 33,395,657 | 33,571,535 | 33,735,944 | 29,677,196 | |||
| Diluted adjusted earnings per share | $ | 0.42 | $ | 1.65 | $ | 1.44 |
All values are in US Dollars.

About Bowhead Specialty Holdings Inc.
Bowhead Specialty is a growing specialty insurance business providing casualty, professional liability and healthcare liability insurance products. We were founded and are led by industry veteran Stephen Sills. The team is composed of highly experienced and respected industry veterans with decades of individual, successful underwriting and management experience. Our products are delivered through two complementary underwriting models designed to support sustainable and profitable growth across market cycles: a “craft” model for large, complex, higher-severity risks, and a “digital” model, which includes Baleen Specialty and other small-business offerings (“express”), for smaller, simpler, and scalable business.
We pride ourselves on the quality and experience of our people, who are committed to exceeding our partners’ expectations through excellent service and expertise. Our collaborative culture spans all functions of our business and allows us to provide a consistent, positive experience for all of our partners.
Conference Call
The Company will host a conference call to discuss its results on the same day, Tuesday, February 24, 2026, beginning at 8:30 a.m. Eastern Time. Interested parties may access the conference call through a live webcast, which can be accessed by going to https://bowhead-4q25-earnings-call.open-exchange.net/registration, or by visiting the Company’s Investor Relations website. A dial-in option for listen-only participants will be available after registering for the call. Please join the live webcast or dial in at least 10 minutes before the start of the call.
A replay of the event webcast will be available on the Company’s Investor Relations website for one year following the call.
Forward-Looking Statements
This press release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in press release are forward-looking statements. In some cases, forward-looking statements can be identified by terms such as "anticipates," "believes," "estimates," "expects," "intends," "plans," "predicts," "projects," "seeks," "future," "outlook," "prospects" "will," "would," "should," "could," "may," "can have" or similar words. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those contemplated by the forward-looking statements. These risks include those described in the Company’s filings made with the Securities and Exchange Commission. Forward-looking statements speak only as of the date of this press release and the Company does not undertake any obligation to update or revise any forward-looking information to reflect changes in assumptions, the occurrence of unanticipated events or otherwise.
Investor Relations Contact:
Shirley Yap, Head of Investor Relations
investorrelations@bowheadspecialty.com
q42025bowheadinvestordec

Investor Presentation February 2026

COLOR PALETTE Text 50 56 62 Title bar/ Bullets 1 23 65 ACCEN TS 1 1 23 65 80 139 252 2 0 148 255 153 212 255 3 234 71 36 247 181 167 4 164 148 31 235 225 149 5 121 26 104 229 135 213 6 83 161 209 186 217 237 Hyperlink 0 148 255 153 212 255 Followed Hyperlink 234 71 36 247 181 167 Line s 50 56 62 Highlights 1 23 65 TABL E 2 Forward-Looking Statements and Other Notices This presentation has been prepared by Bowhead Specialty Holdings Inc. (“we,” “us,” “our,” “Bowhead” or the “Company”) on a confidential basis for the exclusive use of the party to whom Bowhead delivers this presentation. This presentation has been prepared by Bowhead for informational purposes only and not for any other purpose. Nothing contained in this presentation is, or should be construed as, a recommendation, promise or representation by the presenter or Bowhead or any officer, director, employee, agent or advisor of Bowhead. This presentation does not purport to be all inclusive or to contain all of the information you may desire. Information provided in this presentation speaks only as of the date hereof. Bowhead assumes no obligation to update any information or statement after the date of this presentation as a result of new information, subsequent events, or any other circumstances. We request that you keep any information at this meeting confidential and that you do not disclose any of the information to any other parties without the Company's prior express written permission. This presentation contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this presentation, including statements regarding our future results of operations or financial condition, business strategy and plans, and objectives of management for future operations are forward-looking statements. Some of the forward-looking statements can be identified by the use of terms such as “believes”, “expects”, “may”, “will”, “should”, “could”, “seeks”, “intends”, “plans”, “estimates”, “anticipates” or other comparable terms. However, not all forward-looking statements contain these identifying words. These forward-looking statements include all matters that are not related to present facts or current conditions or that are not historical facts. They appear in a number of places throughout this presentation and include statements regarding our intentions, beliefs or current expectations concerning, among other things, our consolidated results of operations, financial condition, liquidity, prospects and growth strategies and the industries in which we operate, and include, without limitation, statements relating to our future performance. Forward-looking statements are subject to known and unknown risks and uncertainties, many of which are beyond our control. Our actual results may differ materially from those expressed in, or implied by, the forward-looking statements included in this presentation as a result of various factors, including, among others, the factors discussed under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2024 and our Quarterly Report on the Form 10-Q for the three months ended March 31, 2025, as well as our other filings with the Securities and Exchange Commission. The forward-looking statements made in this presentation relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statements made in this presentation to reflect events or circumstances after the date of this presentation or to reflect new information or the occurrence of unanticipated events, except as required by law. We may not actually achieve the plans, intentions, or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Unless otherwise indicated, information contained in this presentation concerning our industry and the markets in which we operate, including our general expectations, market position and market opportunity, is based on our management’s estimates and research, as well as industry and general publications and research, surveys and studies conducted by third parties. Industry publications, studies and surveys generally state that they have been obtained from sources believed to be reliable, although they do not guarantee the accuracy or completeness of such information. We believe that the information from these third-party publications, research, surveys and studies included in this presentation is reliable. Management’s estimates are derived from publicly available information, their knowledge of our industry and their assumptions based on such information and knowledge, which we believe to be reasonable. This data involves a number of assumptions and limitations which are necessarily subject to a high degree of uncertainty and risk due to a variety of factors. These and other factors could cause our future performance to differ materially from our assumptions and estimates. This presentation contains references to our trademarks and service marks and to those belonging to other entities. Solely for convenience, trademarks and trade names referred to in this presentation may appear without the ® or ™ symbols, but such references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or the rights of the applicable licensor to these trademarks and trade names. We do not intend our use or display of other companies’ trade names, trademarks or service marks to imply a relationship with, or endorsement or sponsorship of us by, any other companies. “Non-admitted” or excess and surplus (“E&S”) lines refers to policies generally not subject to regulations governing premium rates or policy language. We also consider business written on (i) a facultative reinsurance basis or (ii) an admitted basis through either the New York Free Trade Zone or similar commercial deregulation exemptions available in certain jurisdictions, to be E&S business since such business is generally free of rate and form restrictions. This presentation contains certain financial measures that are not presented in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”). Under U.S. securities laws, these measures are called “non-GAAP financial measures.” We use these non-GAAP financial measures when planning, monitoring and evaluating our performance. We believe these non-GAAP financial measures give our management and other users of our financial information useful insight into our underlying business performance. You should not rely on these non-GAAP financial measures as a substitute for any U.S. GAAP financial measure. While we believe that these non-GAAP financial measures are useful in evaluating our business, this information should be considered supplemental in nature and is not meant to be an alternative to our reported results prepared in accordance with U.S. GAAP. In addition, other companies, including companies in our industry, may calculate such measures differently, which reduces their usefulness as comparative measures. For a reconciliation of such non-GAAP financial measures to the most directly comparable U.S. GAAP financial measures, see the Appendix of this presentation.

COLOR PALETTE Text 50 56 62 Title bar/ Bullets 1 23 65 ACCEN TS 1 1 23 65 80 139 252 2 0 148 255 153 212 255 3 234 71 36 247 181 167 4 164 148 31 235 225 149 5 121 26 104 229 135 213 6 83 161 209 186 217 237 Hyperlink 0 148 255 153 212 255 Followed Hyperlink 234 71 36 247 181 167 Line s 50 56 62 Highlights 1 23 65 TABL E 3 Our Key Investment Highlights Focused on profitable, growing lines in attractive E&S market Ability to deliver differentiated profitability across market cycles Strong underwriting culture with fully-integrated and accountable value chain Highly experienced and entrepreneurial management team Clean balance sheet with no reserves from accident years prior to 2020 Deep, long-standing distribution relationships based on expertise, service and mutual benefit Commitment to long-term value generates strong returns, making us well-positioned for continued growth

COLOR PALETTE Text 50 56 62 Title bar/ Bullets 1 23 65 ACCEN TS 1 1 23 65 80 139 252 2 0 148 255 153 212 255 3 234 71 36 247 181 167 4 164 148 31 235 225 149 5 121 26 104 229 135 213 6 83 161 209 186 217 237 Hyperlink 0 148 255 153 212 255 Followed Hyperlink 234 71 36 247 181 167 Line s 50 56 62 Highlights 1 23 65 TABL E 4 Bowhead: Who We Are Growing and profitable E&S focused specialty P&C business founded and led by industry veteran, Stephen Sills, and supported through a strategic partnership with American Family Mutual Insurance Company, S.I. (“AmFam”) Underwriting-First Culture led by leaders with proven track records “Craft” Tailored solutions in markets with attractive pricing and terms Cycle Management Sustainable underwriting across market cycles “Digital” Tech-enabled underwriting emphasizing speed and disciplined decision making

COLOR PALETTE Text 50 56 62 Title bar/ Bullets 1 23 65 ACCEN TS 1 1 23 65 80 139 252 2 0 148 255 153 212 255 3 234 71 36 247 181 167 4 164 148 31 235 225 149 5 121 26 104 229 135 213 6 83 161 209 186 217 237 Hyperlink 0 148 255 153 212 255 Followed Hyperlink 234 71 36 247 181 167 Line s 50 56 62 Highlights 1 23 65 TABL E 5 Bowhead: By the Numbers Key highlights4 underwriting divisions 2025 GWP: $863MM 64% 20% Professional Liability 13% Casualty Healthcare Liability 96.5% 2025 Combined Ratio1 13.6% 2025 Adjusted ROE2 $863MM 2025 GWP 80% 2025 GWP written on E&S basis 30+ Leadership team average years of experience3 40% 2021 through 2025 GWP CAGR 3% Baleen Specialty Note: 1 Combined ratio for the year ended December 31, 2025 was comprised of a 66.7% loss ratio and a 29.8% expense ratio. 2 2025 adjusted ROE is calculated as adjusted net income divided by the average of mezzanine and stockholders’ equity as of December 31, 2024 and December 31, 2025. Adjusted ROE and adjusted net income are Non-GAAP financial measures. See “Non-GAAP Reconciliation” on slide 19 for a reconciliation of the non-GAAP financial measure to the most directly comparable U.S. GAAP measure; 3 Leadership team includes Stephen Sills, David Newman, Derek Broaddus, Daniel Gamble, Joe Calcagno and Brandon Mezick.

COLOR PALETTE Text 50 56 62 Title bar/ Bullets 1 23 65 ACCEN TS 1 1 23 65 80 139 252 2 0 148 255 153 212 255 3 234 71 36 247 181 167 4 164 148 31 235 225 149 5 121 26 104 229 135 213 6 83 161 209 186 217 237 Hyperlink 0 148 255 153 212 255 Followed Hyperlink 234 71 36 247 181 167 Line s 50 56 62 Highlights 1 23 65 TABL E 6 Highly Experienced and Entrepreneurial Management Team Name and position Years of industry experience Leadership role prior to joining Bowhead Prior professional experience Stephen Sills Founder and CEO 40+ Chairman and CEO of CapSpecialty David Newman Chief Underwriting Officer 40+ Chief Underwriting Officer of Allied World’s Global Markets division Brad Mulcahey Chief Financial Officer 23 Chief Financial Officer of Berkley Select, a division of W.R. Berkley Corp Steve Feltner Chief Operating Officer 15 Vice President, Strategic Finance & Planning at Horace Mann Ayla Boyd, FCAS Chief Actuary 17 Actuarial Manager at Ironshore Insurance Derek Broaddus Head of Casualty 30 Senior Vice President at Allied World Chris Butler, JD Head of Claims 26 Managing Director, Professional Liability Claims at Markel Joe Calcagno Head of Healthcare Liability 23 Vice President, Healthcare at Sompo International – Sompo America Dan Gamble Head of Professional Liability 31 Managing Director, Management & Professional at Markel Brandon Mezick Head of Digital Underwriting 17 Chief Operating Officer of IronHealth at Ironshore Executive Risk

COLOR PALETTE Text 50 56 62 Title bar/ Bullets 1 23 65 ACCEN TS 1 1 23 65 80 139 252 2 0 148 255 153 212 255 3 234 71 36 247 181 167 4 164 148 31 235 225 149 5 121 26 104 229 135 213 6 83 161 209 186 217 237 Hyperlink 0 148 255 153 212 255 Followed Hyperlink 234 71 36 247 181 167 Line s 50 56 62 Highlights 1 23 65 TABL E 7 $27 $28 $29 $29 $31 $34 $39 $46 $61 $73 $83 $95 44.6% 50.4% 49.0% 57.8% 70.9% 63.9% 60.5% 68.1% 62.7% 61.1% 51.0% 53.0% DPW Loss ratio 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Focused on Profitable, Growing Lines in Attractive E&S Market Expanding Commercial E&S Market ($Bn) Bowhead launch (September 2020) Source: S&P Global; Note: E&S premiums sourced per S&P Global based on license types in Schedule T of statutory filings ’20-’24 DPW CAGR: 20% ’20-’24 Avg. Loss Ratio: 59.1%

COLOR PALETTE Text 50 56 62 Title bar/ Bullets 1 23 65 ACCEN TS 1 1 23 65 80 139 252 2 0 148 255 153 212 255 3 234 71 36 247 181 167 4 164 148 31 235 225 149 5 121 26 104 229 135 213 6 83 161 209 186 217 237 Hyperlink 0 148 255 153 212 255 Followed Hyperlink 234 71 36 247 181 167 Line s 50 56 62 Highlights 1 23 65 TABL E 8 100.0% 79.8% 42.1% 41.6% 39.4% 29.1% 24.7% 13.1% —% Focused on Profitable, Growing Lines in Attractive E&S Market (cont’d) E&S Market Share 3 0.6%4 0.7%1.9% 0.7%0.9% 4.2% 3.9% 1.4% 0% E&S Concentration1 2 Source: Company filings, S&P Global. 1 Represents 2024 statutory direct written premiums as a % of 2024 U.S. GAAP GWP; 2 Markel U.S. GAAP GWP includes program services and fronting. 3 Represents 2024 SNL P&C Groups and Affiliated Cos E&S statutory direct written premium as a % of industry total for 2024. 4 Represents American Family Insurance (SNL P&C Group) 2024 statutory E&S direct written premium.

9 Business Mix vs. Specialty Peers GWP CAGR (2021-2024) Source: Company filings, S&P Global. 1 Represents statutory premium for each company's SNL P&C Group. Long-Tail lines include Commercial Multi Peril, Fidelity & Surety, Medical Professional Liability, Other/Product Liability, and Workers’ Compensation. Short-Tail lines include Accident & Health, Aircraft, Commercial Auto, Financial & Mortgage Guaranty, Fire & Allied, Homeowners/Farmowners, Marine Lines, Other Commercial, and Private Auto. 2024 Long-Tail Premium as a % of Total Premium1 1 78.4%95.1% 76.8%3-Year Average Combined Ratio 92.3%85.7%90.1% 95.2% 91.2% 2024 Long-Tail Premium as a % of Total Premium Bowhead writes a low volatility book of business that produces consistent and profitable results 100% 71% 67% 61% 53% 52% 51% 31%

COLOR PALETTE Text 50 56 62 Title bar/ Bullets 1 23 65 ACCEN TS 1 1 23 65 80 139 252 2 0 148 255 153 212 255 3 234 71 36 247 181 167 4 164 148 31 235 225 149 5 121 26 104 229 135 213 6 83 161 209 186 217 237 Hyperlink 0 148 255 153 212 255 Followed Hyperlink 234 71 36 247 181 167 Line s 50 56 62 Highlights 1 23 65 TABL E 10 Strong Underwriting Culture with Fully-Integrated and Accountable Value Chain In-house underwriting expertise Underwriting solutions and product development Integrated actuarial, claims and legal Comprehensive reinsurance program Customized technology platform Long-term distribution relationships • We generally do not delegate underwriting to outside parties, which is a key component of our fully-integrated model • Our unique platform allows us to deliver our custom solutions to clients, while consistently generating underwriting profit across our business

COLOR PALETTE Text 50 56 62 Title bar/ Bullets 1 23 65 ACCEN TS 1 1 23 65 80 139 252 2 0 148 255 153 212 255 3 234 71 36 247 181 167 4 164 148 31 235 225 149 5 121 26 104 229 135 213 6 83 161 209 186 217 237 Hyperlink 0 148 255 153 212 255 Followed Hyperlink 234 71 36 247 181 167 Line s 50 56 62 Highlights 1 23 65 TABL E 11 Craft Products at Founding Craft Products Today Excess Practice Excess Projects Primary Practice Primary Projects Excess Other¹ Primary Other Private D&O E&O Public D&O Financial Institutions Cyber Hospitals Senior Care Managed Care HCML Misc. Medical Facilities Casualty Professional Liability Healthcare Liability D&O Highly experienced team with previous leadership positions at leading insurance companies Specific subject matter experts with proven track records of generating underwriting profits within the lines they write Created primary capabilities across all our products as part of cycle management strategy Strong and disciplined underwriting culture built around rigorous analytical tools (“BRATs”) and cross-functional collaboration (“Roundtables”) Our Key Value Proposition: Underwriting Matters Note: 1 Excess Other includes Public Entity Environmental Digital Evolution: Craft & Digital Bowhead Digital Express Baleen Specialty Ability to Deliver Differentiated Profitability Across Market Cycles

COLOR PALETTE Text 50 56 62 Title bar/ Bullets 1 23 65 ACCEN TS 1 1 23 65 80 139 252 2 0 148 255 153 212 255 3 234 71 36 247 181 167 4 164 148 31 235 225 149 5 121 26 104 229 135 213 6 83 161 209 186 217 237 Hyperlink 0 148 255 153 212 255 Followed Hyperlink 234 71 36 247 181 167 Line s 50 56 62 Highlights 1 23 65 TABL E 12 Clean Balance Sheet with No Reserves from Accident Years Prior to 2020 • 100% cash, short-term investments and investment grade portfolio with no equity or alternative investment risk • Fixed income book and market yields of 4.6% and 4.5% respectively as of December 31, 2025 • Weighted average effective duration of 3.0 years and an average credit rating of “AA” as of December 31, 2025Conservative investment portfolio • Diversified and attractive commercial specialty P&C portfolio with no property or natural-catastrophe exposure • Reflects continuously favorable rate environment with no business or reserves from pre-2020 accident years Free from legacy reserves • No intangibles • 400%+ RBC ratio as of December 31, 2025 • All reinsurers have A.M. Best rating of “A” or better as of December 31, 2025Prudent financial profile

COLOR PALETTE Text 50 56 62 Title bar/ Bullets 1 23 65 ACCEN TS 1 1 23 65 80 139 252 2 0 148 255 153 212 255 3 234 71 36 247 181 167 4 164 148 31 235 225 149 5 121 26 104 229 135 213 6 83 161 209 186 217 237 Hyperlink 0 148 255 153 212 255 Followed Hyperlink 234 71 36 247 181 167 Line s 50 56 62 Highlights 1 23 65 TABL E 13 Robust growth and commitment to long-term value creation Note: 1 Non-GAAP financial measure. See “Non-GAAP Reconciliation” on slide 19 for a reconciliation of the non-GAAP financial measure to the most comparable U.S. GAAP measure. Robust growth Attractive profitability Strong returns Adjusted ROE1Combined Ratio Excess Practice Excess Projects Primary Practice Primary Projects Excess Other Primary Other Private D&O E&O Public D&O Financial Institutions Cyber Hospitals Senior Care Managed Care 94.9% 95.8% 96.5% 63.0% 64.4% 66.7% 31.9% 31.4% 29.8% Expense Ratio Loss Ratio 2023 2024 2025 HCML MMF 19.0% 15.2% 13.6% 2023 2024 2025 $43$26 $56 Adj. net income ($MM)1 GWP ($MM) $224 $357 $508 $696 $863 Casualty Professional Liability Healthcare Liability Baleen Specialty 2021 2022 2023 2024 2025 40% CAGR

COLOR PALETTE Text 50 56 62 Title bar/ Bullets 1 23 65 ACCEN TS 1 1 23 65 80 139 252 2 0 148 255 153 212 255 3 234 71 36 247 181 167 4 164 148 31 235 225 149 5 121 26 104 229 135 213 6 83 161 209 186 217 237 Hyperlink 0 148 255 153 212 255 Followed Hyperlink 234 71 36 247 181 167 Line s 50 56 62 Highlights 1 23 65 TABL E 14 Well-Positioned to Manage Underwriting Cycle Leverage industry relationships to grow in attractive lines Pull back in softening lines while leaning into disrupted lines Expand account size and/or geographic appetite as market allows Add new distribution relationships Develop new products within existing lines Enter new lines/ markets by hiring subject matter experts Having both “craft” and “digital” underwriting models creates flexibility to manage growth and profitability through underwriting cycles Digital Streamlined, tech-enabled, underwriting of small risks • New capability launched late in Q2 2024 • 2.8% of 2025 book (2.5% Baleen; 0.3% Express) • Go-to-market brand: Baleen and Bowhead (Express) • Baleen Specialty Lines: Restrictive Casualty • Express Lines: Small Professional Liability • Distribution: Exclusively major wholesale partners • Paper: Non-admitted • Maintain 100% control of underwriting; no delegated authority • Set clear appetite and rules criteria during product development • Straight-through processing delivers instant quotes, plus low-touch capabilities Craft Individual, custom underwriting of large, complicated risks • 97.2%of 2025 book • Go-to-market brand: Bowhead • Lines: Casualty, Professional Liability and Healthcare Liability • Distribution: Wholesale and retail • Paper: Admitted and non-admitted • Underwriting-first culture • Expertise-driven, customized approach for each risk • Individualized underwriting with collaborative roundtables Bowhead’s long-term growth strategy balances existing “craft” underwriting model with “digital” business launched in 2024

DRAFT: 3/1/2024 Financials

COLOR PALETTE Text 50 56 62 Title bar/ Bullets 1 23 65 ACCEN TS 1 1 23 65 80 139 252 2 0 148 255 153 212 255 3 234 71 36 247 181 167 4 164 148 31 235 225 149 5 121 26 104 229 135 213 6 83 161 209 186 217 237 Hyperlink 0 148 255 153 212 255 Followed Hyperlink 234 71 36 247 181 167 Line s 50 56 62 Highlights 1 23 65 TABL E 16 As of As of As of ($ in thousands) December 31, 2025 December 31, 2024 December 31, 2023 Fixed maturity securities $ 1,371,006 879,989 554,624 Short-term investments — 9,997 8,824 Total investments $ 1,371,006 889,986 563,448 Cash and cash equivalents 193,545 97,476 118,070 Restricted cash and cash equivalents 40,225 124,582 1,698 Accrued investment income 10,958 7,520 4,660 Premium balances receivable 84,415 63,672 38,817 Reinsurance recoverable 399,676 255,072 139,389 Prepaid reinsurance premiums 191,821 152,567 116,732 Deferred policy acquisition costs 35,284 27,625 19,407 Property and equipment, net 10,636 6,845 7,601 Income taxes receivable 3,073 586 1,107 Deferred tax assets, net 22,476 20,340 14,229 Other assets 8,261 7,971 2,701 Total assets $ 2,371,376 1,654,242 1,027,859 Reserves for losses and loss expenses $ 1,129,936 756,859 431,186 Unearned premiums 552,594 446,850 344,704 Reinsurance balances payable 65,778 51,856 40,440 Debt 146,447 — — Income taxes payable 314 1,571 42 Accrued expenses 19,047 18,010 14,900 Other liabilities 7,986 8,654 4,510 Total liabilities $ 1,922,102 1,283,800 835,782 Total mezzanine and stockholders' equity $ 449,274 370,442 192,077 Total liabilities and stockholders' equity $ 2,371,376 1,654,242 1,027,859 Summary Historical Financials Condensed Income Statement Condensed Balance Sheet ($ in thousands, except percentages and per share data) For the years ended Three months ended Revenues: December 31, 2025 December 31, 2024 December 31, 2025 December 31, 2024 Gross written premiums $ 862,806 695,717 224,081 184,769 Net written premiums 558,187 451,422 143,541 120,184 Net earned premiums 491,677 385,111 134,317 106,864 Net investment income 57,827 40,121 16,553 12,193 Total revenue $ 551,589 425,660 151,678 119,331 Net losses and loss adjustment expenses $ 328,022 248,099 91,087 66,937 Net acquisition costs 46,513 32,397 13,166 9,130 Operating expenses 102,264 89,112 26,640 23,352 Non-operating expenses 1,425 2,807 95 622 Warrant expense 3,142 1,917 792 792 Interest expense and financing fees 2,012 725 1,243 248 Loss on extinguishment on credit facility 862 — 862 — Foreign exchange losses (gains) 50 68 (14) 1 Total expenses $ 484,290 375,125 133,871 101,082 Net income $ 53,786 38,243 14,844 13,607 Key Operating and Financial Metrics Underwriting Income1 $ 14,878 18,236 3,424 7,445 Adjusted net income1 $ 55,598 42,686 15,531 14,099 Loss ratio 66.7 % 64.4 % 67.8 % 62.6 % Expense ratio 29.8 % 31.4 % 29.1 % 30.1 % Combined ratio 96.5 % 95.8 % 96.9 % 92.7 % Return on equity2 13.1 % 13.6 % 13.5 % 14.8 % Adjusted return on equity1,2 13.6 % 15.2 % 14.1 % 15.3 % Diluted earnings per share $ 1.59 1.29 0.44 0.41 Diluted adjusted earnings per share1 $ 1.65 1.44 0.47 0.42 Notes: 1 Non-GAAP financial measure. See “Non-GAAP Reconciliation” on slide 19 for a reconciliation of the non-GAAP financial measures to their most directly comparable U.S. GAAP measures; 2 For the three months ended December 31, 2025 and 2024, net income and adjusted net income are annualized to arrive at return on equity and adjusted return on equity.

DRAFT: 3/1/2024 Appendix

COLOR PALETTE Text 50 56 62 Title bar/ Bullets 1 23 65 ACCEN TS 1 1 23 65 80 139 252 2 0 148 255 153 212 255 3 234 71 36 247 181 167 4 164 148 31 235 225 149 5 121 26 104 229 135 213 6 83 161 209 186 217 237 Hyperlink 0 148 255 153 212 255 Followed Hyperlink 234 71 36 247 181 167 Line s 50 56 62 Highlights 1 23 65 TABL E 18 Long-term strategic partnership established at inception AmFam participates in underwriting results and generates fee-based earnings Policies backed by “A” rated paper and ~$12Bn policyholder surplus1 Our Partnership with AmFam Note: 1 AmFam’s policyholder surplus is as of September 30, 2025. ☑ ☑☑ • Originates, issues, and underwrites all Bowhead policies • Provides all claims, actuarial, accounting, reinsurance procurement/processing and other insurance support services • Provides “A” rated paper for business originated by Bowhead • Receives ceding fee • Key agreements with AmFam include 100% Quote Share Agreement and MGA agreements • Assumes 100% of Bowhead policies from AmFam • Purchases reinsurance from high quality reinsurers (including AmFam) Bowhead has operational control over the entire policy lifecycle from distribution through claims management

COLOR PALETTE Text 50 56 62 Title bar/ Bullets 1 23 65 ACCEN TS 1 1 23 65 80 139 252 2 0 148 255 153 212 255 3 234 71 36 247 181 167 4 164 148 31 235 225 149 5 121 26 104 229 135 213 6 83 161 209 186 217 237 Hyperlink 0 148 255 153 212 255 Followed Hyperlink 234 71 36 247 181 167 Line s 50 56 62 Highlights 1 23 65 TABL E 19 Non-GAAP Reconciliation For the years ended Three months ended ($ in thousands, except percentages) December 31, 2025 December 31, 2024 December 31, 2025 December 31, 2024 Adjusted net income2 $ 55,598 42,686 62,124 56,395 Average mezzanine and stockholder’s equity 409,858 281,259 440,156 367,467 Adjusted return on equity 13.6 % 15.2 % 14.1 % 15.3 % For the years ended Three months ended ($ in thousands) December 31, 2025 December 31, 2024 December 31, 2025 December 31, 2024 Pre-Tax After- Tax Pre-Tax After- Tax Pre-Tax After- Tax Pre-Tax After- Tax Income as reported $ 67,299 53,786 50,535 38,243 17,807 14,844 18,249 13,607 Adjustments: Net realized investment (gains) losses (43) (43) 16 16 (73) (73) — — Non-operating expenses 1,425 1,425 2,807 2,807 95 95 622 622 Loss on extinguishment of credit facility 862 862 — — 862 862 — — Foreign exchange losses (gains) 50 50 68 68 (14) (14) 1 1 Strategic initiatives1 — — 2,733 2,733 — — — — Tax impact — (482) — (1,181) — (183) — (131) Adjusted net income $ 69,593 55,598 56,159 42,686 18,677 15,531 18,872 14,099 For the years ended Three months ended ($ in thousands) December 31, 2025 December 31, 2024 December 31, 2025 December 31, 2024 Income before income taxes $ 67,299 50,535 17,807 18,249 Adjustments: Net investment income (57,827) (40,121) (16,553) (12,193) Net realized investment (gains) losses (43) 16 (73) — Other insurance-related income (2,042) (444) (735) (274) Non-operating expenses 1,425 2,807 95 622 Warrant expense 3,142 1,917 792 792 Interest expense and financing fees 2,012 725 1,243 248 Loss on extinguishment of credit facility 862 — 862 — Foreign exchange losses (gains) 50 68 (14) 1 Strategic initiatives1 — 2,733 — — Underwriting income $ 14,878 18,236 3,424 7,445 Note: 1 Strategic initiatives represents costs incurred to set up our Baleen Specialty division, which is recorded in operating expenses within the Condensed Income Statement. The costs incurred primarily represent expenses to implement the new platform and processes supporting the Baleen Specialty division; 2 For the three months ended December 31, 2025 and 2024, adjusted net income is annualized to arrive at adjusted return on equity. For the years ended Three months ended ($ in thousands, except per share data) December 31, 2025 December 31, 2024 December 31, 2025 December 31, 2024 Adjusted net income $ 55,598 42,686 15,531 14,099 Diluted weighted average shares outstanding 33,735,944 29,677,196 33,395,657 33,571,535 Diluted adjusted earnings per share $ 1.65 1.44 0.47 0.42